Northstar By BillionToOne

Partner Level

Gold

Website

Visit Site

Northstar by BillionToOne is a blood-based liquid biopsy platform that delivers ultra-sensitive genomic and methylation analysis to support personalized cancer care.

Powered by proprietary QCT™ technology, Northstar Select® provides comprehensive genomic profiling to guide therapy selection, while Northstar Response® enables real-time monitoring of treatment efficacy through tumor-specific methylation tracking.

Together, they offer a seamless, non-invasive solution for oncology practices—delivering single-molecule precision and faster insights to help clinicians make more informed decisions.